Dynamic Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Dynamic Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17,630	Closed	-$3M	–	175
2018 Q2	$3M	Buy	+17,630	New	+$2.73M	4.79%	2
2018 Q1	–	Sell	-5,081	Closed	-$761K	–	247
2017 Q4	$761K	Sell	5,081 -5,102	-50%	-$755K	0.26%	98
2017 Q3	$1.55M	Buy	10,183 +5,483	+117%	+$825K	0.44%	56
2017 Q2	$606K	Sell	4,700 -34,914	-88%	-$4.2M	0.14%	149
2017 Q1	$4.33M	Buy	39,614 +13,853	+54%	+$1.22M	0.7%	32
2016 Q4	$1.9M	Buy	25,761 +17,525	+213%	+$1.43M	0.2%	168
2016 Q3	$718K	Buy	8,236 +981	+14%	+$92.7K	0.09%	261
2016 Q2	$624K	Sell	7,255 -2,217	-23%	-$192K	0.07%	314
2016 Q1	$753K	Buy	+9,472	New	+$857K	0.28%	95
2015 Q4	–	Sell	-19,004	Closed	-$1.98M	–	464
2015 Q3	$1.98M	Buy	+19,004	New	+$2.44M	0.54%	48
2015 Q2	–	Sell	-3,300	Closed	-$389K	–	358
2015 Q1	$389K	Buy	+3,300	New	+$395K	0.14%	162
2014 Q2	–	Sell	-5,115	Closed	-$362K	–	497
2014 Q1	$362K	Buy	+5,115	New	+$405K	0.12%	300
2013 Q4	–	Sell	-5,828	Closed	-$442K	–	507
2013 Q3	$442K	Buy	+5,828	New	+$464K	0.1%	311

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dynamic Capital Management's VRTX Position: Q3 2018 in Review

Dynamic Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2018, closing a stake of 17,630 shares — an estimated $3M sold.

Dynamic Capital Management first reported a position in VRTX in Q3 2013 and held it in 13 quarters. The position peaked at $4.33M in Q1 2017. 696 funds tracked by Wall St. Rank hold VRTX as of Q3 2018.

Dynamic Capital Management reported no remaining Vertex Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Dynamic Capital Management sold 17,630 Vertex Pharmaceuticals shares in Q3 2018, an estimated $3M.
Dynamic Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2013 and held it in 13 quarters.
Dynamic Capital Management's Vertex Pharmaceuticals position peaked at $4.33M in Q1 2017.
696 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2018.

Based on Dynamic Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.